Substance AbuseNCT00184184
Registration of Tobacco, Coffee and Substance Use Among Acutely Admitted Psychiatric Patients
An observational study of Substance Abuse and Tobacco Use Disorder, run by Norwegian University of Science and Technology at 1 site in Norway.
Trial summary
This is a study of the registration of tobacco, coffee and substance abuse among acutely admitted psychiatric patients. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Substance Abuse, Tobacco Use Disorder
- How many people
- 262 participants
- Where
- 1 siteNorway
- Study dates
- Oct 2004to Jun 2005
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- All patients acutely admitted to Østmarka Psychiatric Hospital
Who cannot join
- Dementia
- Serious brain damage
Trial locations and contacts
1 site in 1 country.
Norway1 site
Østmarka Psychiatric Department, St. Olavs Hospital, University Hospital of Trondheim
Trondheim
About this study
This is a study of the registration of tobacco, coffee and substance abuse among acutely admitted psychiatric patients.
Read the detailed description
We will include all patients acutely admitted to Østmarka Psychiatric Hospital to register this population's use of coffee, tobacco and substances. We will determine whether this differs from other populations, between diagnoses, age, etc.
We will also compare results of substance in immunologic rapid urine tests taken by the nurse at the hospital with substance in urine tested in laboratory with LC/MS (liquid chromatography/mass spectrometry).
- Conditions
- Substance Abuse, Tobacco Use Disorder
- Keywords
- Emergency Services, Psychiatric, Tobacco use cessation, Coffee use cessation, substance use detection, Substance Abuse Detection
- Medical subject headings
- Substance-Related Disorders, Tobacco Use Disorder, Tobacco Use Cessation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Sep 2005 (estimated)
- Study startOct 2004
- Primary completionJun 2005
- Study completionJun 2005
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Substance AbuseStudies of the same condition, open and under way.
- More trials run by Norwegian University of Science and TechnologyThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Time perspective
- Prospective
- Enrolment
- 262 participants (actual)
Sponsor and investigators
- Lead sponsor
- Norwegian University of Science and Technology
- Sponsor type
- University, hospital or other
- Collaborators
- St. Olavs Hospital
- Responsible party
- Sponsor
- Investigators
- Gunnar Morken, MD, PhD, Principal investigator, Norwegian ministry of Education and Research
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00184184
- Sponsor's protocol ID
- GB- TKR 2004
- Status last verified
- Mar 2017
- First submitted
- 12 Sep 2005
- Last updated
- 14 Mar 2017
- Results posted
- No
Publications
Bagoien G, Morken G, Zahlsen K, Aamo T, Spigset O. Evaluation of a urine on-site drugs of abuse screening test in patients admitted to a psychiatric emergency unit. J Clin Psychopharmacol. 2009 Jun;29(3):248-54. doi: 10.1097/JCP.0b013e3181a45e78.
PubMed 19440078
Study at a glance
From the registry record, last updated by the sponsor on 14 Mar 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Registration of Tobacco, Coffee and Substance Use Among Acutely Admitted Psychiatric Patients
- ClinicalTrials.gov ID
- NCT00184184
- Acronym / sponsor ID
- GB- TKR 2004
- Conditions
- Substance Abuse, Tobacco Use Disorder
- Keywords
- Emergency Services, Psychiatric, Tobacco use cessation, Coffee use cessation, substance use detection, Substance Abuse Detection
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 262 participants (actual)
- Lead sponsor
- Norwegian University of Science and TechnologyUniversity, hospital or other
- Collaborators
- St. Olavs Hospital
- Study start
- Oct 2004 (actual)
- Primary completion
- Jun 2005 (actual)
- Study completion
- Jun 2005 (actual)
- First posted
- 16 Sep 2005 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a study of the registration of tobacco, coffee and substance abuse among acutely admitted psychiatric patients.
Detailed description
We will include all patients acutely admitted to Østmarka Psychiatric Hospital to register this population's use of coffee, tobacco and substances. We will determine whether this differs from other populations, between diagnoses, age, etc.
We will also compare results of substance in immunologic rapid urine tests taken by the nurse at the hospital with substance in urine tested in laboratory with LC/MS (liquid chromatography/mass spectrometry).
Study design
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- All patients acutely admitted to Østmarka Psychiatric Hospital
Key exclusion criteria (2 listed)
- Dementia
- Serious brain damage
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Mar 2017.
- Results publication: PubMed 19440078Bagoien G, Morken G, Zahlsen K, Aamo T, Spigset O. Evaluation of a urine on-site drugs of abuse screening test in patients admitted to a psychiatric emergency unit. J Clin Psychopharmacol. 2009 Jun;29(3):248-54. doi: 10.1097/JCP.0b013e3181a45e78.
Related trials for Substance Abuse
RecruitingPhase 3
Nabilone for Agitation Blinded Intervention Trial
Alzheimer Disease, Agitation
Recruiting
The Trans-Led Care Study
Substance Abuse, Substance Addiction
Active, not recruitingPhase 1
Psilocybin-assisted Treatment for Cannabis Use Disorder
Cannabis Use Disorder
Not yet recruitingEarly Phase 1
Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis
Cannabis Use, Tobacco
Recruiting
Young Adult Tobacco/Nicotine and Cannabis Co-use
Tobacco Use Disorder, Nicotine Dependence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gunnar Morken, MD, PhD principal investigator
Norwegian ministry of Education and Research
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Substance Abuse and Tobacco Use Disorder, run by Norwegian University of Science and Technology at 1 site in Norway.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Mar 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00184184, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Mar 2017.